ShangBay Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
99
- Portfolio
-
60
- Exits
-
18
ShangBay Capital General Information
Company Description
Founded in 2015, ShangBay Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in companies operating in the life sciences, medical devices, biotechnology, and mobile healthcare sectors across the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.shangbaycapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 789 University Avenue
- Palo Alto, CA 94301
- United States
ShangBay Capital Investments (99)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| SoundHealth | 30-Jul-2026 | Later Stage VC | Therapeutic Devices | Generating Revenue | ||
| Contraline | 17-Jun-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Nervonik | 20-Apr-2026 | Therapeutic Devices | Generating Revenue | |||
| MedLink Global | 30-Jan-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| SetPoint Medical | 28-Oct-2025 | Therapeutic Devices | Generating Revenue | |||
| Petal Surgical | 29-Aug-2025 | Surgical Devices | Generating Revenue | |||
| Restera | 21-Jul-2025 | Therapeutic Devices | Generating Revenue | |||
| Brava | 02-May-2025 | Therapeutic Devices | Generating Revenue | |||
| Evident Vascular | 25-Mar-2025 | Early Stage VC | Diagnostic Equipment | Generating Revenue | ||
| Fluid Biomed | 16-Dec-2024 | Later Stage VC | Therapeutic Devices | Generating Revenue |
ShangBay Capital Exits (18)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Tvardi Therapeutics | 15-Apr-2025 | Reverse Merger | |
| Ceribell | 11-Oct-2024 | ||
| Refuge Biotech | 03-Aug-2023 | ||
| Alpine BioTherapeutics | 26-May-2023 | ||
| Lucira Health | 22-Feb-2023 | ||
| QuanDx | 01-Dec-2022 | ||
| Apexigen | 01-Aug-2022 | ||
| Qool Therapeutics | 12-Oct-2021 | ||
| DeVoro Medical | 21-Sep-2021 | Merger/Acquisition | |
| Falcon Therapeutics | 15-Sep-2021 | Bankruptcy: Liquidation |
ShangBay Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
ShangBay Capital Co-Investors (186)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Boston Scientific | 2 |
|
|
||
| Deerfield Management |
|
|
|||
| Founders Fund |
|
|
|||
| Lumira Ventures |
|
|
|||
| U.S. Venture Partners |
|
|
ShangBay Capital FAQs
-
What is ShangBay Capital?
Founded in 2015, ShangBay Capital is a venture capital firm based in Palo Alto, California.
-
When was ShangBay Capital founded?
ShangBay Capital was founded in 2015.
-
Where is ShangBay Capital headquartered?
ShangBay Capital is headquartered in Palo Alto, CA.
-
What is ShangBay Capital's total asset value?
ShangBay Capital has around in total assets under management.
-
How many investments has ShangBay Capital made?
ShangBay Capital has made 99 investments.
-
What has ShangBay Capital invested in?
ShangBay Capital has made numerous investments in companies like SoundHealth, Contraline, and Nervonik within the Therapeutic Devices and Drug Discovery industries.
-
What has ShangBay Capital invested in recently?
ShangBay Capital's latest investment was on 30-Jul-2026 in SoundHealth, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
